[Use of rectal diazepam administration for control of epileptic seizures in children. A multicenter study]

J Czochańska1

  • 1Klinika Neurologii Dzieci i Młodziezy IMD, Instytut Matki i Dziecka w Warszawie.

Medycyna Wieku Rozwojowego
|July 27, 2000
PubMed

Insights

Rectal diazepam effectively and safely treats prolonged seizures in 98% of children. This rapid-acting treatment is recommended for all medical settings and home use by caregivers.

Area of Science:

  • Pediatric Neurology
  • Emergency Medicine
  • Clinical Pharmacology

Background:

  • Prolonged convulsions and status epilepticus are medical emergencies in children.
  • Prompt and effective seizure termination is crucial to prevent neurological damage.
  • Rectal diazepam is a potential first-line treatment option.

Purpose of the Study:

  • To evaluate the efficacy and safety of rectal diazepam administration using a rectal appliance.
  • To assess the onset of action and success rate of this treatment in children.

Main Methods:

  • A multicentre study involving 178 children with prolonged convulsions or status epilepticus.
  • Rectal administration of diazepam via a specialized rectal appliance.
  • Data collection on seizure termination, onset of action, and adverse events.

Main Results:

  • Diazepam was effective in terminating seizures in 98% of the studied children.
  • The treatment demonstrated a rapid onset of action.
  • Rectal diazepam was found to be safe for pediatric use.

Conclusions:

  • Rectal administration of diazepam via a rectal appliance is a highly effective and safe treatment for pediatric seizures.
  • The rapid onset and high efficacy support its use across various medical settings.
  • This method is suitable for administration by healthcare professionals and caregivers at home.

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...